USANA HEALTH SCIENCES, INC. Cash and Restricted Cash
USANA HEALTH SCIENCES, INC. (USNA) had Cash and Restricted Cash of $171.51 million as of 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-07-04: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $171.51M.
- 2026-04-04: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $165.66M.
- 2026-01-03: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $161.24M.
- 2025-09-27: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $148.15M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-04 | $171.51M 10-Q · filed 2026-08-13 |
| 2026-04-04 | $165.66M 10-Q · filed 2026-05-12 |
| 2026-01-03 | $161.24M 10-K · filed 2026-03-16 |
| 2025-09-27 | $148.15M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $154.13M 10-Q · filed 2026-08-13 |
| 2025-03-29 | $182.37M 10-Q · filed 2026-05-12 |
| 2024-12-28 | $184.51M 10-K · filed 2026-03-16 |
| 2024-09-28 | $367.74M 10-Q · filed 2025-11-05 |
| 2024-06-29 | $335.18M 10-Q · filed 2025-08-05 |
| 2024-03-30 | $331.11M 10-Q · filed 2025-05-06 |
| 2023-12-30 | $333.25M 10-K · filed 2026-03-16 |
| 2023-09-30 | $309.82M 10-Q · filed 2024-11-05 |
| 2023-07-01 | $302.94M 10-Q · filed 2024-08-06 |
| 2023-04-01 | $298.37M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $291.32M 10-K · filed 2025-03-12 |
| 2022-10-01 | $250.36M 10-Q · filed 2023-11-07 |
| 2022-07-02 | $234.03M 10-Q · filed 2023-08-08 |
| 2022-04-02 | $241.57M 10-Q · filed 2023-05-09 |
| 2022-01-01 | $243.65M 10-K · filed 2024-02-27 |
| 2021-10-02 | $251.89M 10-Q · filed 2022-11-08 |
| 2021-07-03 | $268.55M 10-Q · filed 2022-08-09 |
| 2021-04-03 | $260.07M 10-Q · filed 2022-05-11 |
| 2021-01-02 | $315.94M 10-K · filed 2023-02-28 |
| 2020-09-26 | $281.35M 10-Q · filed 2021-11-10 |
| 2020-06-27 | $230.19M 10-Q · filed 2021-08-11 |
| 2020-03-28 | $196.92M 10-Q · filed 2021-05-11 |
| 2019-12-28 | $237.69M 10-K · filed 2022-03-01 |
| 2019-09-28 | $185.56M 10-Q · filed 2020-11-03 |
| 2019-06-29 | $234.26M 10-Q · filed 2020-08-04 |
| 2019-03-30 | $228.02M 10-Q · filed 2020-05-05 |
| 2018-12-29 | $217.23M 10-K · filed 2021-03-02 |
| 2018-09-29 | $242.77M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $259.46M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $269.71M 10-Q · filed 2019-05-07 |
| 2017-12-30 | $250.53M 10-K · filed 2020-02-25 |
| 2017-09-30 | $195.06M 10-Q · filed 2018-11-07 |
| 2017-07-01 | $232.62M 10-Q · filed 2018-08-08 |
| 2017-04-01 | $179.55M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $178.95M 10-K · filed 2020-02-25 |
| 2016-01-02 | $146.73M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |